Atossa Genetics Secures $6,600,000 New Round

  • Feed Type
  • Date
    6/27/2011
  • Company Name
    Atossa Genetics
  • Mailing Address
    4105 E Madison St Seattle, WA 98112
  • Company Description
    We are a healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer.
  • Website
    http://www.atossagenetics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,600,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds from the offering will be used to produce the MACST System in commercial quantities; establish a cytology and molecular diagnostics laboratory focused on breast health; launch the Mammary Aspirate Specimen Cytology Test System (MASCT System) in the Northwestern United States, including hiring and training sales personnel; continue development of the second generation MASCT System; and develop additional products and services.
  • M&A Terms
  • Venture Investor
    Undisclosed